Eli Lilly and Company

LLY

New York Stock Exchange. Currency in USD

323.35 -6.66 ( -2.02% )

Real time prices: September 30

Market Cap.
307.24B
Beta (5Y monthly)
0.38
Price/Earnings
39.76
EPS (TTM)
8.30
Forward Dividend
3.92 (1.26%)
Ex-Dividend Date
Aug 15, 2022
Volume
4.47M
1y Target Est.
304.28
Day's Range
322.42
-
329.51
52 Week's Range
224.22
-
341.70

Historical Summary

Performance
EPS growth
Share Buybacks

About Eli Lilly and Company

Sector
Healthcare
Industry
Drug Manufacturers-General
Website
https://www.lilly.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
956.59M
Employees
35000
Address
Lilly Corporate Center, Indianapolis, IN, United States, 46285
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Latest news

3 Growth Stocks Poised to Skyrocket
3 Growth Stocks Poised to Skyrocket

Two of these three stocks are already soaring this year.
By The Motley Fool - 1 day ago

Gina Sanchez makes a bull case for Eli Lilly & Co
Gina Sanchez makes a bull case for Eli Lilly & Co

Eli Lilly & Co (NYSE: LLY) will continue to do well even as the U.S....
By Invezz - 1 day ago

Eli Lilly's Donanemab: Nearing The End Of The Line For Anti-Amyloid Drugs
Eli Lilly's Donanemab: Nearing The End Of The Line For Anti-Amyloid Drugs

Anti-amyloid drugs only modestly slow down the progression of Alzheimer's in APOE4 carriers and have...
By Seeking Alpha - 2 days ago

What Fast Food And Entertainment Giants Did Traders Pick For CNBC's Fast Money Call Of The Day
What Fast Food And Entertainment Giants Did Traders Pick For CNBC's Fast Money Call Of The Day

CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts...
By Benzinga - 2 days ago

Insiders Selling Foot Locker, Dave And This Drug Giant's Stock
Insiders Selling Foot Locker, Dave And This Drug Giant's Stock

The Nasdaq Composite dropped by over 300 points on Thursday. Investors, meanwhile, focused on some...
By Benzinga - 2 days ago

LLY & PRTA in Spotlight on BIIB-Eisai's AD Drug Data
LLY & PRTA in Spotlight on BIIB-Eisai's AD Drug Data

The success of Biogen (BIIB)-Eisai's AD candidate in a big phase III study makes investors...
By Zacks Investment Research - 3 days ago

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced...
By Benzinga - 3 days ago

Netflix, Biogen And Other Big Gainers From Wednesday
Netflix, Biogen And Other Big Gainers From Wednesday

U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday....
By Benzinga - 4 days ago